InvestorsHub Logo

sicofbs

09/14/16 7:51 AM

#119906 RE: koronis #119905

That press release is a bigger lie than the similar failed one 5 years before it ..Dabney ..ly our a liar and a thief and hopefully you will live out your life in a cab starting real soon you pos...anyway folks there is no lab..office...products...grow..studies..clinical a. Dabney is a pathological liar
CANNABIS SCIENCE NEGOTIATES COMMERCIALIZATION DEAL TO BRING CANNABIS SCIENCE BRAND FORMULATIONS IMMEDIATELY INTO THE CALIFORNIA MARKET

December 14, 2011

DENVER--(BUSINESS WIRE)-- Cannabis Science, Inc. (OTCBB:CBIS.ob), a pioneering US biotech company developing pharmaceutical cannabis products, is pleased to announce it has entered final negotiations to bring Cannabis Science Brand of Pharmaceutical products into California.

Following the release of our cannabis extract based formulation in Colorado, and international anecdotal cases reports from patients with Cancer, Cannabis Science is finalizing agreements to expand our business into California.

This new strategic partnership would allow Cannabis Science to better satisfy the demand for its formulations by making them available to more than 1.4 million cancer patients in California. This strategic alliance also brings to the table significant resources for Cannabis Science in California including laboratories for quality assurance and testing, an educational platform to distribute information about the science of cannabis (everything on should know from the seed to sale) Additionally, as part of the deal we will acquire organically produced strains for our scientific medicinal formulations. Furthermore, if California goes fully legal in 2014, it should bring down production costs and savings could be passed along to the patients.

Dr. Melamede stated “ For too long patients have requested our formulations, as a result we have gathered anecdotal reports thru personal testimonials that have demonstrated to us the need for our products in California. We look forward to bringing these products thru the California regulatory system in the near future. Similarly, as the laws allow, we intend to bring our products to other medical marijuana states through additional strategic mergers, acquisitions, and partnerships

sicofbs

09/14/16 1:59 PM

#119911 RE: koronis #119905

This is what you said Dabney ...please update shareholders...did you fail again....or were you just padding your wallet with false and misleading news...l...really address this ..lie or failure again !!!
CANNABIS SCIENCE ORDERS FIRST BATCH INHALATION MEDICATION AND ADDS CBIS MDI RESCUE INHALER FOR ASTHMA/COPD VIA NEBULIZER, TARGETING 25+ LEGAL STATES, AND NATIONAL MARKET VARIABLES

IRVINE, CA--(Marketwired - Aug 11, 2016) - Cannabis Science, Inc. (OTC PINK: CBIS), a U.S. company specializing in the development of cannabis based medicines, is happy to announce their first batch order for the previously announced cannabinoid based inhalation medicine for Asthma/COPD has been placed. It is expected to be received by the company within a week and released initially in select California dispensaries and available for delivery. The CBIS MDI Rescue Inhaler dosage is targeting 100 - 200 dose MDI with cannabinoid level variations ranging from 10mg, 25mg, up to 100mg THC, CBD, and other cannabinoid variables as patient/consumer analysis moves further down the road.